{"id":41097,"date":"2025-10-25T07:00:00","date_gmt":"2025-10-25T07:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4806049_CN06049_0"},"modified":"2025-10-25T07:00:00","modified_gmt":"2025-10-25T07:00:00","slug":"cardiovalve-completes-target-study-enrollment-for-ce-registration-study-for-tricuspid-valve-replacement","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=41097","title":{"rendered":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement"},"content":{"rendered":"<div id=\"dvContent\" readability=\"87\">\n<p><b><span id=\"spanHghlt87a9\">The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch<\/span><\/b><\/p>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">HANGZHOU, China<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 25, 2025<\/span><\/span> \/PRNewswire\/ &#8212;&nbsp;Venus&nbsp;Medtech (<span class=\"xn-location\">Hangzhou<\/span>) Inc. (2500.HK, hereinafter referred to as the &#8220;Company&#8221;) today announced the successful completion of patient enrollment in the <b>Cardiovalve TARGET study<\/b> for Transcatheter Tricuspid Valve Replacement (TTVR), with a total of <b>150 patients enrolled<\/b>. The completion of enrollment marks a major milestone toward European regulatory approval for Cardiovalve&#8217;s <b>Transcatheter Tricuspid Valve Replacement (TTVR) system<\/b>, the company&#8217;s flagship solution for treating tricuspid regurgitation.<\/p>\n<p>With enrollment now complete, the company is preparing to submit its <b>CE Mark application<\/b> to European regulators later this year. Pending approval, <b>commercial launch of the Cardiovalve TR system in <span class=\"xn-location\">Europe<\/span> is projected for 2027<\/b>.<\/p>\n<p>Building on this achievement, Cardiovalve is also preparing to initiate its <b>AHEAD study<\/b>, which will evaluate the safety and performance of Cardiovalve&#8217;s <b>mitral valve replacement system<\/b> in patients suffering from significant mitral regurgitation (MR). The AHEAD study is designed to support a future <b>CE Mark application<\/b> for the mitral system.<\/p>\n<p><b>Cardiovalve Participation at TCT 2025<\/b><\/p>\n<p>Cardiovalve will present preliminary data for its mitral regurgitation (MR) system at <b>TCT 2025<\/b>.<\/p>\n<p>The presentation, titled &#8220;Transcatheter Mitral Valve Replacement Using the New Generation Cardiovalve System,&#8221; will be led by <b>Dr. <span class=\"xn-person\">Christian Frerker<\/span>.<\/b><\/p>\n<p><b>Session Details<\/b>:<\/p>\n<ul type=\"disc\">\n<li><b>Session<\/b>: Innovation Session 17 \u2014 New Generation Transcatheter Mitral Technologies: Case-in-a-Box Demonstrations<\/li>\n<li><b>Date<\/b>: <span class=\"xn-chron\">Tuesday, October 28, 2025<\/span><\/li>\n<li><b>Time<\/b>: 12:25\u201312:30 PM<\/li>\n<li><b>Location<\/b>: Moscone Center, North, Exhibition Level, Hall E- Innovation Theatre<\/li>\n<\/ul>\n<p><b>About Cardiovalve<\/b><\/p>\n<p>A subsidiary of <b>Venus Medtech<\/b>, <b>Cardiovalve<\/b> is a pioneer in transcatheter valve replacement technology, standing at the forefront of innovation in structural heart therapy. With more than <b>150 approved patents<\/b>, a highly experienced team, and a <b>state-of-the-art manufacturing facility<\/b>, Cardiovalve is dedicated to providing physicians with next-generation solutions that improve patient outcomes and quality of life\u2014without the need for open-heart surgery.<\/p>\n<p><b>About Venus Medtech<\/b><\/p>\n<p><b>Venus Medtech (<span class=\"xn-location\">Hangzhou<\/span>) Inc. (2500.HK)<\/b> is a leading innovator in transcatheter heart valve solutions for structural heart disease. The company has developed a comprehensive product pipeline covering all four heart valves \u2014 <b>TAVR, TPVR, TMVR, and TTVR<\/b> \u2014and related accessory products. With global R&amp;D centers in <span class=\"xn-location\">China<\/span>, <span class=\"xn-location\">the United States<\/span>, and <span class=\"xn-location\">Israel<\/span>, The company is committed to providing effective treatment solutions for life-threatening diseases.<\/p>\n<\/p><\/div>\n<p>Source: Venus Medtech (Hangzhou) Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 \/PRNewswire\/ &#8212;&nbsp;Venus&nbsp;Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the &#8220;Company&#8221;) today announced the successful completion of patient enrollment in the Cardiovalve TARGET study for Transcatheter Tricuspid Valve Replacement (TTVR), with a [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-41097","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=41097\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog\" \/>\n<meta property=\"og:description\" content=\"The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 \/PRNewswire\/ &#8212;&nbsp;Venus&nbsp;Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the &#8220;Company&#8221;) today announced the successful completion of patient enrollment in the Cardiovalve TARGET study for Transcatheter Tricuspid Valve Replacement (TTVR), with a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=41097\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-25T07:00:00+00:00\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement\",\"datePublished\":\"2025-10-25T07:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097\"},\"wordCount\":384,\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097\",\"name\":\"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"datePublished\":\"2025-10-25T07:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=41097#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=41097","og_locale":"en_US","og_type":"article","og_title":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog","og_description":"The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 \/PRNewswire\/ &#8212;&nbsp;Venus&nbsp;Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the &#8220;Company&#8221;) today announced the successful completion of patient enrollment in the Cardiovalve TARGET study for Transcatheter Tricuspid Valve Replacement (TTVR), with a [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=41097","og_site_name":"My Blog","article_published_time":"2025-10-25T07:00:00+00:00","author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=41097#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41097"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement","datePublished":"2025-10-25T07:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41097"},"wordCount":384,"articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=41097","url":"https:\/\/transmediavictoria.net.au\/?p=41097","name":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"datePublished":"2025-10-25T07:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=41097#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=41097"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=41097#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/41097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41097"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/41097\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}